Search Results - "Tortelli, Tharcísio Citrângulo"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Emerging targets for combination therapy in melanomas by Saito, Renata de Freitas, Tortelli, Tharcísio Citrângulo, Jacomassi, Mayara D’Auria, Otake, Andréia Hanada, Chammas, Roger

    Published in FEBS letters (14-11-2015)
    “…Cutaneous melanomas are often difficult to treat when diagnosed in advanced stages. Melanoma cells adapt to survive in extreme environmental conditions and are…”
    Get full text
    Journal Article
  3. 3

    deltaXpress (ΔXpress): a tool for mapping differentially correlated genes using single-cell qPCR data by Murillo Carrasco, Alexis Germán, Furuya, Tatiane Katsue, Uno, Miyuki, Citrangulo Tortelli, Tharcisio, Chammas, Roger

    Published in BMC bioinformatics (27-10-2023)
    “…High-throughput experiments provide deep insight into the molecular biology of different species, but more tools need to be developed to handle this type of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Sulforaphane: An emergent anti-cancer stem cell agent by Coutinho, Leandro de Lima, Junior, Tharcísio Citrangulo Tortelli, Rangel, Maria Cristina

    Published in Frontiers in oncology (23-01-2023)
    “…Cancer is a major public health concern worldwide responsible for high morbidity and mortality rates. Alternative therapies have been extensively investigated,…”
    Get full text
    Journal Article
  6. 6

    Stochastic model of contact inhibition and the proliferation of melanoma in situ by Morais, Mauro César Cafundó, Stuhl, Izabella, Sabino, Alan U., Lautenschlager, Willian W., Queiroga, Alexandre S., Tortelli, Tharcisio Citrangulo, Chammas, Roger, Suhov, Yuri, Ramos, Alexandre F.

    Published in Scientific reports (14-08-2017)
    “…Contact inhibition is a central feature orchestrating cell proliferation in culture experiments; its loss is associated with malignant transformation and…”
    Get full text
    Journal Article
  7. 7

    Abstract 5598: Interaction between BRAF inhibitor PLX-4720 and CDK inhibitors can sensitize melanoma cells with BRAF V600E mutation by Tortelli, Tharcísio Citrângulo, Chammas, Roger, Chellappan, Srikumar

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…BRAF V600E mutation happens in 60% of all melanomas cases and this mutation is responsible to poor prognosis of the disease. BRAF is part of the MAPK signaling…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Role of galectin-3 in the elastic response of radial growth phase melanoma cancer cells by Herrera-Reinoza, Nataly, Tortelli Junior, Tharcisio Citrangulo, Teixeira, Fernanda de Sá, Chammas, Roger, Salvadori, Maria Cecília

    Published in Microscopy research and technique (01-10-2023)
    “…Melanoma is originated from the malignant transformation of the melanocytes and is characterized by a high rate of invasion, the more serious stage…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Abstract 5548: Indicators of immune activation upon p14ARF and interferon-beta gene transfer in a human melanoma cell line by Cerqueira, Otto Luiz, Salomon, Maria Alejandra, Cardoso, Elaine Cristina, Tortelli, Tharcisio Citrangulo, Strauss, Bryan Eric

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Immunoevasion adopted by tumor cells is an important cancer hallmark and understanding of its mechanisms has generated promising therapeutic approaches. In…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16